Skip to main navigation Skip to search Skip to main content

N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial

  • Zhi Wei Lai
  • , Robert Hanczko
  • , Eduardo Bonilla
  • , Tiffany N. Caza
  • , Brandon Clair
  • , Adam Bartos
  • , Gabriella Miklossy
  • , John Jimah
  • , Edward Doherty
  • , Hajra Tily
  • , Lisa Francis
  • , Ricardo Garcia
  • , Maha Dawood
  • , Jianghong Yu
  • , Irene Ramos
  • , Ioana Coman
  • , Stephen V. Faraone
  • , Paul E. Phillips
  • , Andras Perl

Research output: Contribution to journal › Article › peer-review

380   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry

Neuroscience